Regional volumetric change in Parkinson's disease with cognitive decline

Journal of the Neurological Sciences

Volumn 373, Issue , 2017, Pages 88-94

  Gee, Myrlene ^a   Dukart, Juergen ^b,c   Draganski, Bogdan ^c   Wayne Martin, W R ^a   Emery, Derek ^a   Camicioli, Richard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cognitive decline; Dementia; Magnetic resonance imaging; Parkinson's disease; Statistical parametric mapping

Indexed keywords

AGED; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN SIZE; BRAIN STEM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; LEFT HIPPOCAMPUS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROMONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PARKINSON DISEASE; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; DIAGNOSTIC IMAGING; DISEASE COURSE; LONGITUDINAL STUDY; MENTAL HEALTH; ORGAN SIZE; PATHOPHYSIOLOGY; PSYCHOLOGY;

ANTIPARKINSON AGENT;

AGED; ANTIPARKINSON AGENTS; ATROPHY; BRAIN; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; ORGAN SIZE; PARKINSON DISEASE;

EID: 85007092572     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2016.12.030     Document Type: Article

References (42)

1. [1] Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A., Jansen Steur, E.N., Braak, E., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24:2 (2003), 197–211.
2. [2] Ganga, G., Alty, J.E., Clissold, B.G., McColl, C.D., Reardon, K.A., Schiff, M., Kempster, P.A., Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase. Mov. Disord. 28:4 (2013), 476–481.
3. [3] Aarsland, D., Andersen, K., Larsen, J.P., Lolk, A., Kragh-Sørensen, P., Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 60:3 (2003), 387–392.
4. [4] Hely, M.A., Reid, W.G., Adena, M.A., Halliday, G.M., Morris, J.G., The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23:6 (2008), 837–844.
5. [5] Aarsland, D., Larsen, J.P., Tandberg, E., Laake, K., Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J. Am. Geriatr. Soc. 48:8 (2000 Aug), 938–942.
6. [6] de Lau, L.M., Verbaan, D., Marinus, J., van Hilten, J.J., Survival in Parkinson's disease. Relation with motor and non-motor features. Parkinsonism Relat. Disord. 20:6 (2014 Jun), 613–616.
7. [7] Duncan, G.W., Firbank, M.J., O'Brien, J.T., Burn, D.J., Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?. Mov. Disord. 28:4 (2013), 425–438.
8. [8] Mak, E., Su, L., Williams, G.B., O'Brien, J.T., Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease. Parkinsonism Relat. Disord. 21:8 (2015), 862–870.
9. [9] Burton, E.J., McKeith, I.G., Burn, D.J., O'Brien, J.T., Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov. Disord. 20:12 (2005), 1571–1576.
10. [10] Ramírez-Ruiz, B., Martí, M.J., Tolosa, E., Bartrés-Faz, D., Summerfield, C., Salgado-Pineda, P., Gómez-Ansón, B., Junqué, C., Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J. Neurol. 252:11 (2005), 1345–1352.
11. [11] Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., Santangelo, G., Foltynie, T., Janvin, C., Larsen, J.P., Barker, R.A., Emre, M., Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:12 (2010), 1062–1069.
12. [12] Pereira, J.B., Svenningsson, P., Weintraub, D., Brønnick, K., Lebedev, A., Westman, E., Aarsland, D., Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology 82:22 (2014), 2017–2025.
13. [13] Wen, M.C., Ng, A., Chander, R.J., WL, A., Tan, L.C., Kandiah, N., Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease. Parkinsonism Relat. Disord. 21:5 (2015), 483–488.
14. [14] Mak, E., Su, L., Williams, G.B., Firbank, M.J., Lawson, R.A., Yarnall, A.J., Duncan, G.W., Owen, A.M., Khoo, T.K., Brooks, D.J., Rowe, J.B., Barker, R.A., Burn, D.J., O'Brien, J.T., Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain 138:Pt 10 (2015), 2974–2986.
15. [15] Duncan, G.W., Firbank, M.J., Yarnall, A.J., Khoo, T.K., Brooks, D.J., Barker, R.A., Burn, D.J., O'Brien, J.T., Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson's disease?. Mov. Disord. 31:1 (2016), 103–110.
16. [16] Jia, X., Liang, P., Li, Y., Shi, L., Wang, D., Li, K., Longitudinal study of gray matter changes in Parkinson disease. AJNR Am. J. Neuroradiol. 36:12 (2015), 2219–2226.
17. [17] Ibarretxe-Bilbao, N., Junque, C., Segura, B., Baggio, H.C., Marti, M.J., Valldeoriola, F., Bargallo, N., Tolosa, E., Progression of cortical thinning in early Parkinson's disease. Mov. Disord. 27:14 (2012), 1746–1753.
18. [18] Tessa, C., Lucetti, C., Giannelli, M., Diciotti, S., Poletti, M., Danti, S., Baldacci, F., Vignali, C., Bonuccelli, U., Mascalchi, M., Toschi, N., Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. Hum. Brain Mapp. 35:8 (2014), 3932–3944.
19. [19] Melzer, T.R., Myall, D.J., MacAskill, M.R., Pitcher, T.L., Livingston, L., Watts, R., Keenan, R.J., Dalrymple-Alford, J.C., Anderson, T.J., Tracking Parkinson's disease over one year with multimodal magnetic resonance imaging in a group of older patients with moderate disease. PLoS One, 10(12), 2015 Dec 29, e0143923, 10.1371/journal.pone.0143923. eCollection 2015.
20. [20] Lewis, M.M., Du, G., Lee, E.Y., Nasralah, Z., Sterlin, N.W., Zhang, L., Wagner, D., Kong, L., Tröster, A.I., Styner, M., Eslinger, P.J., Mailman, R.B., Huang, X., The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions. J. Neurol. 263:1 (2016), 68–75.
21. [21] Mollenhauer, B., Zimmermann, J., Sixel-Döring, F., Focke, N.K., Wicke, T., Ebentheuer, J., Schaumburg, M., Lang, E., Trautmann, E., Zetterberg, H., Taylor, P., Friede, T., Trenkwalder, C., DeNoPa study group. Monitoring of 30 marker candidates in early Parkinson disease as progression markers. Neurology 87:2 (2016), 168–177.
22. [22] Camicioli, R., Sabino, J., Gee, M., Bouchard, T., Fisher, N., Hanstock, C., Emery, D., Martin, W.R., Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia. Mov. Disord. 26:8 (2011), 1443–1450.
23. [23] Sapkota, S., Gee, M., Sabino, J., Emery, D., Camicioli, R., Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease. Mov. Disord. 29:3 (2014), 368–374.
24. [24] Braak, H., Rüb, U., Jansen Steur, E.N., Del Tredici, K., de Vos, R.A., Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:8 (2005), 1404–1410.
25. [25] Hughes, A.J., Daniel, S.E., Ben-Shlomo, Y., Lees, A.J., The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:Pt 4 (2002), 861–870.
26. [26] Camicioli, R., Majumdar, S.R., Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-year prospective cohort study. Gait Posture. 32:1 (2010), 87–91.
27. [27] American Psychiatric Association, Diagnostic and Statistical Manual. fourth ed., 2000 Arlington, VA.
28. [28] Ashburner, J., A fast diffeomorphic image registration algorithm. NeuroImage 38:1 (2007), 95–113.
29. [29] Ashburner, J., Friston, K.J., Voxel-based morphometry—the methods. NeuroImage 11:6 Pt 1 (2000), 805–821.
30. [30] Radua, J., Jorge Canales-Rodríguez, E.J., Pomarol-Clotet, E., Raymond Salvador, R., Validity of modulation and optimal settings for advanced voxel-based morphometry. NeuroImage 86 (2014), 81–90.
31. [31] Friston, K.J., Holmes, A., Poline, J.-B., Price, C.J., Frith, C.D., Detecting activations in PET and fMRI: levels of inference and power. NeuroImage 4:3 (1996), 223–235.
32. [32] Hayasaka, S., Nichols, T.E., Validating cluster size inference: random field and permutation methods. NeuroImage 20:4 (2003), 2343–2356.
33. [33] Hayasaka, S., Luan Phan, K., Liberzon, I., Worsley, K.J., Nichols, T.E., Nonstationary cluster-size inference with random field and permutation methods. NeuroImage 22:2 (2004), 676–687.
34. [34] Worsley, K.J., Marrett, S., Neelin, P., Vandal, A.C., Friston, K.J., Evans, A.C., A unified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 4 (1996), 58–73.
35. [35] Ibarretxe-Bilbao, N., Ramirez-Ruiz, B., Junque, C., Marti, M.J., Valldeoriola, F., Bargallo, N., Juanes, S., Tolosa, E., Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J. Neurol. Neurosurg. Psychiatry 81:6 (2010), 650–657.
36. [36] Baba, T., Kikuchi, A., Hirayama, K., Nishio, Y., Hosokai, Y., Kanno, S., et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 135:Pt 1 (2012), 161–169.
37. [37] Hanganu, A., Bedetti, C., Degroot, C., Mejia-Constain, B., Lafontaine, A.L., Soland, V., Chouinard, S., Bruneau, M.A., Mellah, S., Belleville, S., Monchi, O., Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Brain 137:Pt 4 (2014), 1120–1129.
38. [38] Lin, C.-H., Ruey-Meei, W., Biomarkers of cognitive decline in Parkinson's disease. Parkinsonism Relat. Disord. 21 (2015), 431–443.
39. [39] Barton, B.R., Bernard, B., Czernecki, V., Goldman, J.G., Stebbins, G., Dubois, B., Goetz, C.G., Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing. Mov. Disord. 29:10 (2014), 1252–1257.
40. [40] Halliday, G., Hely, M., Reid, W., Morris, J., The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol. 115:4 (2008 Apr), 409–415.
41. [41] Jubault, T., Brambati, S.M., Degroot, C., Kullmann, B., Strafella, A.P., Lafontaine, A.L., Chouinard, S., Monchi, O., Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS One, 4(12), 2009, e8247.
42. [42] Pickut, B.A., Van Hecke, W., Kerckhofs, E., Mariën, P., Vanneste, S., Cras, P., Parizel, P.M., Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: a randomized controlled longitudinal trial. Clin. Neurol. Neurosurg. 115:12 (2013 Dec), 2419–2425.